reports
- MarketLine Department
British American Tobacco p.l.c. - Mergers & Acquisitions (M&A), Partne...
Summary Marketline's British American Tobacco p.l.c. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by British American Tobacco p.l.c. since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensiv...
- Valens Research
Valens Equity Insights and Inflections - 2018 04 11
INTU currently trades at historical highs relative to UAFRS-based (Uniform) Earnings, with a 29.7x Uniform P/E. At these levels, the market is pricing in expectations for Uniform ROA to expand rapidly, from 40% in 2017 to 83% by 2022, accompanied by 1% Uniform Asset growth going forward. However, analysts have less bullish expectations, projecting Uniform ROA to only improve to 43% levels through 2019, accompanied by 4% Uniform Asset growth. Moreover, Valens' qualitative analysis of the firm's Q...
WD5 TRAVEL + LEISURE CO.
TJX TJX COMPANIES INC
SYY SYSCO CORPORATION
KFY KORN FERRY
INTU INTUIT INC.
FIS FIDELITY NATIONAL INFORMATION SERVICES INC.
ECL ECOLAB INC.
CVI CVR ENERGY INC.
AVON. AVON PRODUCTS INC.
AN AUTONATION INC.
AMT AMERICAN TOWER CORPORATION
AL AIR LEASE CORPORATION CLASS A
ADBE ADOBE INC.
VOW VOLKSWAGEN AG
2914 JAPAN TOBACCO INC.
MCK MCKESSON CORPORATION
MGM MGM RESORTS INTERNATIONAL
NSC NORFOLK SOUTHERN CORPORATION
AAPL APPLE INC.
PETR3 PETROLEO BRASILEIRO SA
AVGO BROADCOM INC.
- Valens Research
2914 JPN - Embedded Expectations Analysis - 2018 04 03
Japan Tobacco Inc. (2914:JPN) currently trades above historical averages relative to UAFRS-based (Uniform) Earnings, with a 19.5x Uniform P/E, implying fairly bullish expectations for the firm. However, management has concerns about their profits, portfolio, and regulation Specifically, management may lack confidence in the sustainability of gross profit improvements in their Pharmaceutical and Processed Food businesses, and may be downplaying concerns about their reduced risk products. Moreove...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.